Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Clinical trial NCT00620061 · COMPLETED

Trial details

NCT number: NCT00620061
Sponsor: Sucampo Pharma Americas, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid-Induced Bowel Dysfunction

Start date: 2007-12-01
Primary completion: 2009-09-01
Enrollment: 439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.